Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Product recall for Ketofen 10% Solution for Injection
Veterinary surgeons, retailers and wholesale dealers are asked to examine inventory.
Visual inspection confirmed possibility of particulate contamination. 

Ceva Animal Health has recalled Ketofen 10% Solution for Injection.

The Class II recall was initiated after a visual inspection confirmed a possibility of particulate contamination, which is unacceptable for an intravenous use preparation. 

Only the following batches have been recalled:
    •   108AB Expiry 12/02/2023
    •   113H Expiry 16/03/2023

Veterinary surgeons, retailers and wholesale dealers are being contacted and told to examine inventory immediately, and then quarantine any products subject to recall. 

Ketofen 10% Solution for Injection is used to treat cattle, horses and other equidae, and pigs, and is a non-narcotic, non-steroidal anti-inflammatory agent with analgesic and anti-pyretic properties. 

Anyone with further questions on the recall is advised to contact Peter Kyte on +44 1494 781510 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.